Delivery Order SPE2DB20D3303-SPE2DB24FZ8B8
- Not listed
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of the pharmaceutical product MOUNJARO 15 MG/0.5 ML PEN 0.5ML to the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a ceiling value of $3,156.00 and a period of performance through June 25, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of the pharmaceutical product MOUNJARO 5 MG/0.5 ML PEN 0.5ML. The $5,260.00 fixed-price delivery order was awarded on June 5, 2024 by the Defense Logistics Agency (DLA), with a scheduled completion date of June 6, 2024. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of the pharmaceutical product MOUNJARO 5 MG/0.5 ML PEN 0.5ML. The $14,906.00 firm fixed price contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical on June 24, 2024, with a completion date of June 25, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, is for the supply of the medication MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML to the Defense Logistics Agency (DLA). The $1,506.00 delivery order contract has an ultimate completion date of April 30, 2024. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of the pharmaceutical product MOUNJARO 5 MG/0.5 ML PEN 0.5ML to the Defense Logistics Agency (DLA). The delivery order contract, valued at $7,926.48, has a firm fixed price and an ultimate completion date of June 4, 2024. This award is not associated with a set-aside program. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract...
- This federal contract award to AmerisourceBergen Drug Corp, Corporate Office Division, is for the delivery of MOUNJARO 10 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a division of the Department of Defense, and has a ceiling value of $2,802.89. The contract is a Delivery Order with a Firm Fixed Price pricing type, has no set-aside designation, and has an ultimate completion date of August 28, 2024....
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of the pharmaceutical product Mounjaro 10 mg/0.5 ml pen (0.5 ml) to the Defense Logistics Agency (DLA). The contract has a ceiling value of $1,052.00 and an ultimate completion date of July 12, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the procurement of pharmaceutical products, specifically the drug Mounjaro 10 mg/0.5 mL pen, for a ceiling value of $2,448.84. The contract is a delivery order issued by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of June 25, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of the pharmaceutical product MOUNJARO 10 MG/0.5 ML PEN 0.5ML. The contract, valued at $4,150.23, was awarded by the Defense Logistics Agency (DLA) Troop Support Medical on June 20, 2024 and has an ultimate completion date of June 21, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, provides for the delivery of the pharmaceutical product Mounjaro 5 mg/0.5 ml pen 0.5 ml to the U.S. government. The contract, valued at $11,337.24, is a Firm Fixed Price Delivery Order awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA, valued up to...
- SPE2DB20D3303Indefinite Delivery Contract
- SPE2DB20D3303-SPE2DB24FZ8B8Delivery Order
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of the pharmaceutical product MOUNJARO 5 MG/0.5 ML PEN 0.5ML. The contract has a ceiling value of $1,578.00 and a completion date of May 23, 2024. It was awarded by the Defense Logistics Agency (DLA), a defense agency that provides logistics, acquisition, and technical services to the U.S. Armed Forces and other government agencies. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The company also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024. This contract award does not have a set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 5/22/24 |